MaxCyte, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 15.67 million compared to USD 12.42 million a year ago. Net loss was USD 5.28 million compared to USD 4.81 million a year ago.

Basic loss per share from continuing operations was USD 0.05 compared to USD 0.05 a year ago.